Efficacy in current practice of switching between anti-tumour necrosis factor-α agents in spondyloarthropathies

René-Marc Flipo

首页> 外文期刊>Rheumatology >Efficacy in current practice of switching between anti-tumour necrosis factor-α agents in spondyloarthropathies

【24h】

Efficacy in current practice of switching between anti-tumour necrosis factor-α agents in spondyloarthropathies

机译：在脊椎关节病中抗肿瘤坏死因子-α药物之间进行切换的当前实践中的功效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective. Anti-TNF-α agents are remarkably effective in the treatment of SpAs. However, 30% of patients withdraw from anti-TNF-α agents yearly because of inadequate efficacy or side effects. The objective of this study was to assess in current practice the response to a second and a third anti-TNF-α.

机译：目的。抗TNF-α剂在治疗SpAs中非常有效。但是，由于疗效或副作用不足，每年有30％的患者退出抗TNF-α药物治疗。这项研究的目的是评估当前实践中对第二种和第三种抗TNF-α的反应。

著录项

来源
《Rheumatology》 |2011年第4期|p.714-720|共7页
作者
René-Marc Flipo;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy in current practice of switching between anti-tumour necrosis factor- alpha agents in spondyloarthropathies. [J] . Paccou J, Solau Gervais E, Houvenagel E, Rheumatology . 2011,第4期

机译：在脊椎关节病的抗肿瘤坏死因子-α药物之间进行切换的当前实践中的功效。
2. Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor- alpha agents for the treatment of ulcerative colitis (vol 39, pg 660, 2014) [J] . Waljee A. K. Alimentary pharmacology & therapeutics. . 2015,第1期

机译：通过网络荟萃分析进行系统回顾：抗肿瘤坏死因子-α药物治疗溃疡性结肠炎的疗效（第39卷，第660页，2014年）
3. Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? [J] . Finckh A, Ciurea A, Brulhart Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2010,第2期

机译：抗风湿性关节炎患者先前失败后，哪类亚组的风湿性关节炎患者可以从利妥昔单抗转用抗肿瘤坏死因子（TNF）替代治疗？
4. Anti-tumour necrosis factor therapy in clinical practice: what is advance and what is not? [C] . Falk Symposium . 2004

机译：临床实践中的抗肿瘤坏死因子治疗：什么是进步，什么不是？
5. AN APPRAISAL OF CURRENT STATUS, PRACTICES AND PROCEDURES IN THE USE OF FISCAL AGENTS IN RELATION TO SCHOOL BOND ISSUES [D] . ASHE, JOHN LAWRENCE -1

机译：与学校债券问题有关的使用财务代理的最新状态，做法和程序的评估
6. Extended report: Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? [O] . A Finckh, A Ciurea, L Brulhart, -1

机译：扩展报告：先前使用抗TNF药物失败后与替代抗肿瘤坏死因子（TNF）药物相比哪种类风湿关节炎患者受益于改用利妥昔单抗？
7. Increased Serum Tumour Necrosis Factor- in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor- Agents? [O] . L Matusiak, A Bieniek, JC Szepietowski 2009

机译：血清肿瘤坏死因素增加了Hidradenitis患者：是否存在抗肿瘤坏死因子剂治疗的基础？

相关主题

Efficacy in current practice of switching between anti-tumour necrosis factor-α agents in spondyloarthropathies

摘要

著录项

相似文献

相关主题

期刊订阅